Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data

Clicks: 166
ID: 112016
2016
Abstract. Background. Rotavirus vaccination reduces childhood hospitalization in Africa, but cost-effectiveness has not been determined using real-world effect
Reference Key
naor2016clinicalcost-effectiveness Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bar-Zeev, Naor;for the VACSURV Consortium;Tate, Jacqueline E.;for the VACSURV Consortium;Pecenka, Clint;for the VACSURV Consortium;Chikafa, Jean;for the VACSURV Consortium;Mvula, Hazzie;for the VACSURV Consortium;Wachepa, Richard;for the VACSURV Consortium;Mwansambo, Charles;for the VACSURV Consortium;Mhango, Themba;for the VACSURV Consortium;Chirwa, Geoffrey;for the VACSURV Consortium;Crampin, Amelia C.;for the VACSURV Consortium;Parashar, Umesh D.;for the VACSURV Consortium;Costello, Anthony;for the VACSURV Consortium;Heyderman, Robert S.;for the VACSURV Consortium;French, Neil;for the VACSURV Consortium;Atherly, Deborah;for the VACSURV Consortium;Cunliffe, Nigel A.;for the VACSURV Consortium;for the VACSURV Consortium;Beard, James;Iturriza-Gomara, Miren;Jere, Khuzwayo;King, Carina;Lewycka, Sonia;Nakagomi, Osamu;Phiri, Tambosi;Verani, Jennifer R.;Whitney, Cynthia G.;
Journal clinical infectious diseases
Year 2016
DOI DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.